Do AdiaVita stem cells plus glutathione help kids with autism more than glutathione alone?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional phase 1 trial randomizes about 100 children with confirmed autism to two groups. One group receives monthly IV AdiaVita plus IV glutathione for 3 months, while the control group receives IV glutathione plus a saline placebo for 2 months; both groups use a topical glutathione spray at home. Autism symptoms are tracked using the Autism Treatment Evaluation Checklist (ATEC) completed by parents and by a clinician or teacher, with safety monitored through 12 months. A potential crossover allows initial glutathione-only participants to receive AdiaVita if they remain medically stable. Participation requires a study fee of $12,000 and adherence to visits and procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 3-12 years
* Confirmed ASD diagnosis (DSM-5 criteria, supported by ADOS-2)
* Parent/guardian willingness to consider experimental treatments and comply with study requirements
* Ability to attend all scheduled visits
* Able to meet study cost requirements ($12,000 study fee plus bloodwork costs, if applicable) as described in the informed consent

Exclusion Criteria:

* Severe allergies to study products
* Significant uncontrolled medical conditions
* Pregnancy or breastfeeding (if applicable)
* Participation in another interventional trial within 30 days
* Prior stem cell or glutathione therapy: History of stem cell therapy (including umbilical cord blood-derived stem cells or exosomes) or glutathione therapy (intravenous or topical) at any time prior to screening

Where it's running

• Adia Med Of Winter Park
  Winter Park, Florida, United States Recruiting
• The Lyday Center
  Green Bay, Wisconsin, United States Recruiting

Study contacts

• Study coordinator: Larry Powalisz
• Email: research@adiamed.com
• Phone: 3217880850

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AdiaVita and glutathione for autism in kids and teens

  This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.

  Recruiting at 2 sites Phase 1 Greater Atlanta Integrative Pediatrics · Roswell, Georgia and 1 other locations · NCT07622316

• Online test of BlinkLab Dx1 for autism in kids aged 2–11

  This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.

  Recruiting Blinklab Limited · Princeton, New Jersey · NCT07590973

• Comparing center-based and home-based treatment for young children with autism

  This study tests whether treatment for young children with autism works better when done at a center or at home, focusing on improving their language and social skills.

  Recruiting Stanford University · Stanford, California · NCT04899544

• Museum visits to support social and emotional well‑being in autistic adults

  This study tests whether visiting the National Taiwan Museum can help improve social participation and well-being for autistic adults aged 18–50.

  Recruiting National Taiwan University Hospital · Taipei · NCT07768332

• Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions

  This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.

  Recruiting Healing Hope International · The Woodlands, Texas · NCT07493096

• Gut barrier and gut microbes in children with autism

  This trial will test whether a one-month course of postbiotic supplements can improve gut symptoms and behavior in children with autism aged 3–8.

  Recruiting at 2 sites Phase 2/3 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Milan, MI and 1 other locations · NCT07450443

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.